Is Bausch + Lomb considering a sale?

A Private equity could be “the most likely” buyer of the eye care business, analysts from JP Morgan wrote in the FT last week.

Bausch + Lomb is exploring a potential sale that would separate the eye care company from parent firm Bausch Health, says the Financial Times  on Saturday, citing unnamed sources.

A private equity firm could be a likely buyer, J.P. Morgan and Needham analysts wrote in research notes. “There are only a few strategics that would make sense, in our view, and all would likely run into anti-trust challenges,” Needham analyst David Saxon wrote in a Monday note to clients.

Bausch + Lomb commented  “We don’t comment on speculation or rumour.”